Conjugate Vaccine Market Size, Share & Trends Report

Conjugate Vaccine Market Size, Share & Trends Analysis Report By Product (Monovalent, Multivalent), By Brand (Prevnar, CAPVAXIVE), By Disease, By Pathogen, By Patient, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-349-3
Number of Report Pages: 150
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

Conjugate Vaccines Product Outlook (Revenue, USD Million, 2018 - 2030)
- Influenza Conjugate Vaccine
- Multivalent Conjugate Vaccine
Conjugate Vaccines Brand Outlook (Revenue, USD Million, 2018 - 2030)
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
Conjugate Vaccines Disease Outlook (Revenue, USD Million, 2018 - 2030)
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
Conjugate Vaccines Pathogen Outlook (Revenue, USD Million, 2018 - 2030)
- Bacterial
- Viral
- Combination
Conjugate Vaccines Patient Outlook (Revenue, USD Million, 2018 - 2030)
- Pediatric
- Adults
Conjugate Vaccines Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Conjugate Vaccines Market, by product
- Influenza Conjugate Vaccine
- Multivalent Conjugate Vaccine
- North America Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- North America Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- North America Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- North America Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- U.S.
- U.S. Conjugate Vaccines Market, by product
- Influenza Conjugate Vaccine
- Multivalent Conjugate Vaccine
- U.S. Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- U.S. Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- U.S. Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- U.S. Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Canada
- Canada Conjugate Vaccines Market, by product
- Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Canada Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Canada Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Canada Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Canada Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Mexico
- Mexico Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Mexico Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Mexico Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Mexico Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Mexico Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Europe
- Europe Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Europe Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Europe Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Europe Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Europe Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- UK
- UK Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- UK Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- UK Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- UK Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- UK Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Germany
- Germany Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Germany Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Germany Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Germany Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Germany Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- France
- France Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- France Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- France Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- France Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- France Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Italy
- Italy Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Italy Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Italy Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Italy Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Italy Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Spain
- Spain Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Spain Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Spain Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Spain Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Spain Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Denmark
- Denmark Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Denmark Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Denmark Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Denmark Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Denmark Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Sweden
- Sweden Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Sweden Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Sweden Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Sweden Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Sweden Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Norway
- Norway Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Norway Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Norway Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Norway Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Norway Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Asia Pacific
- Asia Pacific Conjugate Vaccines Market, by product
- Influenza Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Asia Pacific Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Asia Pacific Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Asia Pacific Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Asia Pacific Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Japan
- Japan Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Japan Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Japan Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Japan Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Japan Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- hina
- China Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- China Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- China Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- China Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- China Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- India
- India Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- India Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- India Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- India Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- India Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Australia
- Australia Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Australia Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Australia Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Australia Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Australia Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- South Korea
- South Korea Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- South Korea Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- South Korea Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- South Korea Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- South Korea Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Thailand
- Thailand Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Thailand Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Thailand Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Thailand Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Thailand Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Latin America
- Latin America Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Latin America Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Latin America Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Latin America Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Latin America Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Brazil
- Brazil Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Brazil Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Brazil Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Brazil Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Brazil Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Argentina
- Argentina Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Argentina Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Argentina Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Argentina Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Argentina Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Middle East and Africa
- Middle East and Africa Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Middle east and Africa Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Middle East and Africa Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Middle East and Africa Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Middle East and Africa Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- South Africa
- South Africa Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- South Africa Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- South Africa Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- South Africa Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- South Africa Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Saudi Arabia
- Saudi Arabia Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Saudi Arabia Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Saudi Arabia Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Saudi Arabia Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Saudi Arabia Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- UAE
- UAE Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- UAE Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- UAE Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- UAE Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- UAE Conjugate Vaccines Market, by patient
- Pediatric
- Adults
- Kuwait
- Kuwait Conjugate Vaccines Market, by product
- Monovalent Conjugate Vaccine
- Multivalent Conjugate Vaccine
- Kuwait Conjugate Vaccines Market, by brand
- Prevnar
- Synflorix
- PedvaxHIB
- Hiberix
- ACT-HIB
- Pentacel
- Menveo
- Menactra
- MenQuadfi
- VAXNEUVANCE
- CAPVAXIVE
- Others
- Kuwait Conjugate Vaccines Market, by disease
- Pneumococcal
- Influenza
- DTP
- Meningococcal
- Typhoid
- Kuwait Conjugate Vaccines Market, by pathogen
- Bacterial
- Viral
- Combination
- Kuwait Conjugate Vaccines Market, by patient
- Pediatric
- Adults

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.